Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers (Q57808582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

1 reference

9

J Erin Staples

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

8

Marc Fischer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1

Nicole P Lindsey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

5

Olga I Kosoy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

4

Amanda J Panella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

6

Jason O Velez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

2

Kalanthe A Horiuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Elizabeth R Krow-Lucal

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Corey Fulton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

1 January 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

Journal of Travel Medicine

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

Imported yellow fever in vaccinated tourist

29 April 2020

cites work

1 reference

12 December 2020

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine

1 reference

12 December 2020

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

12 December 2020

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

1 reference

12 December 2020

A fatal case of yellow fever in a European in Uganda.

1 reference

12 December 2020

Duration of immunity after yellow fever vaccination

1 reference

12 December 2020

Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine

1 reference

12 December 2020

Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine.

1 reference

12 December 2020

Immunity to yellow fever nine years after vaccination with 17D vaccine

1 reference

12 December 2020

Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil

1 reference

12 December 2020

Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002.

1 reference

12 December 2020

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients

1 reference

12 December 2020

Yellow fever virus 17D neutralising antibodies in vaccinated Colombian people and unvaccinated ones having immunity against dengue

1 reference

12 December 2020

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines

1 reference

12 December 2020

Long term persistence of yellow fever neutralising antibodies in elderly persons

1 reference

12 December 2020

Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil

1 reference

12 December 2020

Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study

1 reference

12 December 2020

Vaccines and vaccination against yellow fever. WHO position paper -- June 2013

1 reference

12 December 2020

Yellow fever revaccination guidelines change - a decision too feverish?

1 reference

12 December 2020

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

1 reference

12 December 2020

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

1 reference

12 December 2020

The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases

1 reference

12 December 2020

Duration of post-vaccination immunity against yellow fever in adults

1 reference

12 December 2020

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.

1 reference

12 December 2020

Booster dose after 10 years is recommended following 17DD-YF primary vaccination

1 reference

12 December 2020

Questions regarding the safety and duration of immunity following live yellow fever vaccination

1 reference

12 December 2020

Yellow fever virus: Increasing imported cases in China

1 reference

12 December 2020

Notes from the Field: Fatal Yellow Fever in a Traveler Returning From Peru - New York, 2016.

1 reference

12 December 2020

Single shot of 17D vaccine may not confer life-long protection against yellow fever

1 reference

12 December 2020

Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018.

1 reference

12 December 2020

Fatal Yellow Fever in Travelers to Brazil, 2018.

1 reference

12 December 2020

Yellow fever in two unvaccinated French tourists to Brazil, January and March, 2018

1 reference

12 December 2020

Yellow fever cases in French Guiana, evidence of an active circulation in the Guiana Shield, 2017 and 2018

1 reference

12 December 2020

Identifiers

DOI

10.1093/JTM/TAY108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30346562%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30346562

1 reference